Skip to main content
SpringerLink
Log in

Levodopa/carbidopa/entacapone in early Parkinson's disease

  • Unknown
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Liao XL, et al. Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis. Neurological Sciences : 11 Mar 2020. Available from: URL: https://doi.org/10.1007/s10072-020-04303-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levodopa/carbidopa/entacapone in early Parkinson's disease. Reactions Weekly 1798, 10 (2020). https://doi.org/10.1007/s40278-020-76747-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-76747-2

Search

Navigation